Skip to main content

Table 2 Clinicopathological characteristics of the 162 patients in association with P-cadherin expression

From: Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study

  P-cadherin  
Variable Low High P-value
Age, mean ± SD (years) 55.8 ± 11.5 55.7 ± 12.9 .428
PS (no.)    .627
  0 52 67  
  1 11 20  
  2 or 3 4 8  
CA125 a(no.)    .262
  ≤136 37 42  
  > 136 30 51  
  NA 0 2  
Stage b(FIGO2014) (no.)    .0024*
  Stage I/II 46 42  
  Stage III/IV 21 53  
Peritoneal dissemination (no.)    2.7e-5*
  Positive 18 58  
  Negative 49 37  
Lymph node metastasis b(no.)    .823
  Positive 9 15  
  Negative 58 80  
Distant site metastasis (no.)    .048*
  Positive 1 9  
  Negative 65 86  
Histologic typeb (no.)    1.37e-10*
  Clear cell 30 4  
  Endometrioid 9 21  
  Mucinous 12 11  
  Serous 16 59  
  1. Clinicopathological characteristics of the 162 patients in association with P-cadherin expression
  2. *P < 0.05. aCutoff value as the median value. bPathological diagnosis. NA not available